Level of unique T cell clonotypes is associated with clonal hematopoiesis and survival in patients with lymphoma undergoing ASCT.

Saved in:
Bibliographic Details
Title: Level of unique T cell clonotypes is associated with clonal hematopoiesis and survival in patients with lymphoma undergoing ASCT.
Authors: Husby S; Department of Hematology, Rigshospitalet, Copenhagen, Denmark. simon.husby.01@regionh.dk.; Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark. simon.husby.01@regionh.dk.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark. simon.husby.01@regionh.dk., Jørgensen GØ; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark., Favero F; Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark., Jespersen JS; Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark., Rodriguez-Gonzalez FG; Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark., Nielsen C; Department of Clinical Immunology, Odense University Hospital, Odense, Denmark.; Centre for Cellular Immunotherapy of Haematological Cancer Odense (CITCO), Odense University Hospital, Odense, Denmark., Sorensen B; Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark., Ebbesen LH; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Bæch J; Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark., Haastrup EK; Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark., Josefsson P; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Thorsgaard M; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Brown P; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., El-Galaly TC; Department of Hematology, Aalborg University Hospital, Aalborg, Denmark., Larsen TS; Centre for Cellular Immunotherapy of Haematological Cancer Odense (CITCO), Odense University Hospital, Odense, Denmark.; Department of Hematology, Odense University Hospital, Odense, Denmark., Weischenfeldt J; Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark., Grønbæk K; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Source: Bone marrow transplantation [Bone Marrow Transplant] 2022 Apr; Vol. 57 (4), pp. 674-677. Date of Electronic Publication: 2022 Feb 05.
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5365
DOI:10.1038/s41409-022-01580-2